US 8383583
Macrocyclic, pyridazinone-containing hepatitis C serine protease inhibitors
granted A61KA61K31/13A61K31/505
Quick answer
US patent 8383583 (Macrocyclic, pyridazinone-containing hepatitis C serine protease inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Feb 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/13, A61K31/505, A61K31/7056, A61K38/21